You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 16, 2025

Drug Price Trends for ammonium lactate


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for ammonium lactate

Average Pharmacy Cost for ammonium lactate

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
AMMONIUM LACTATE 12% LOTION 51672-1300-05 0.06311 GM 2025-11-19
AMMONIUM LACTATE 12% CREAM 51672-1301-04 0.05996 GM 2025-11-19
AMMONIUM LACTATE 12% LOTION 45802-0419-54 0.06311 GM 2025-11-19
AMMONIUM LACTATE 12% CREAM 45802-0493-26 0.07064 GM 2025-11-19
AMMONIUM LACTATE 12% LOTION 45802-0419-26 0.06875 GM 2025-11-19
AMMONIUM LACTATE 12% CREAM 45802-0493-83 0.05996 GM 2025-11-19
AMMONIUM LACTATE 12% CREAM 51672-1301-00 0.07064 GM 2025-11-19
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for ammonium lactate

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
AMMONIUM LACTATE 12% CREAM,TOP Nnodum Pharmaceuticals Corporation 63044-0404-20 140GM 5.53 0.03950 GM 2024-01-01 - 2028-12-31 FSS
AMMONIUM LACTATE 12% LOTION,TOP Nnodum Pharmaceuticals Corporation 63044-0484-09 225GM 5.53 0.02458 GM 2024-01-01 - 2028-12-31 FSS
AMMONIUM LACTATE 12% CREAM,TOP Golden State Medical Supply, Inc. 51672-1301-00 385GM 17.80 0.04623 GM 2023-06-23 - 2028-06-14 FSS
AMMONIUM LACTATE 12% CREAM,TOP Golden State Medical Supply, Inc. 51672-1301-04 2x140GM 10.39 2023-06-15 - 2028-06-14 FSS
AMMONIUM LACTATE 12% LOTION Golden State Medical Supply, Inc. 51672-1300-05 225GM 29.14 0.12951 GM 2023-06-15 - 2028-06-14 FSS
AMMONIUM LACTATE 12% CREAM,TOP Golden State Medical Supply, Inc. 51672-1301-04 2x140GM 11.24 2023-06-23 - 2028-06-14 FSS
AMMONIUM LACTATE 12% LOTION Golden State Medical Supply, Inc. 51672-1300-05 225GM 31.49 0.13996 GM 2023-06-23 - 2028-06-14 FSS
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Unit >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Market Analysis and Price Projections for Ammonium Lactate

Last updated: July 27, 2025

Introduction

Ammonium lactate, a synthetic compound combining ammonium hydroxide and lactic acid, is widely used in dermatology and skincare primarily as a moisturizer and treatment for dry, rough, or scaly skin conditions. Its applications extend to managing hyperkeratosis, xerosis, and other dermatological ailments. Given its prevalent formulation in both OTC and prescription products, understanding the market landscape and pricing dynamics is essential for pharmaceutical manufacturers, investors, and healthcare providers.

Market Landscape Overview

Global Market Size and Growth Trends

The global ammonium lactate market is experiencing steady expansion driven by increasing dermatological conditions, escalating geriatric populations, and rising awareness of skincare. As of 2022, the market was valued approximately at $50 million, with a projected compound annual growth rate (CAGR) of 5-7% through 2027 [1].

Key growth regions include North America, Europe, and Asia-Pacific, with the latter showing rapid growth attributable to burgeoning skincare industries and health awareness initiatives. The North American market currently dominates owing to high healthcare expenditure and widespread dermatology awareness.

Key Drivers

  • Rising prevalence of dry skin conditions and hyperkeratotic disorders: Aging populations and climate factors contribute to increased demand for emollients containing ammonium lactate [2].
  • Expansion of dermatological treatment options: Dermatologists increasingly recommend ammonium lactate-based formulations as first-line or adjunct therapies, favoring topical applications.
  • Growing cosmetics and OTC skincare segments: Consumer shift toward moisturizing and anti-aging products incorporating ammonium lactate as a key ingredient enhances market growth.
  • Innovation and formulation diversity: Development of new, stable, and more bioavailable formulations increases market appeal.

Competitive Landscape

Major pharmaceutical and skincare companies, including L'Oréal, Johnson & Johnson, and generic manufacturers, produce ammonium lactate formulations. The market’s fragmentation is moderate, with some regional players focusing on niche dermatological markets and OTC segments. Patent expirations of some formulations have increased generic competition, exerting downward pressure on prices.

Regulatory and Supply Factors

Ammonium lactate’s regulatory status is straightforward in major markets, with approvals primarily granted as dermatological lubricants or emollients. The compound’s synthetic nature and established safety profile facilitate market entry but also lead to commoditization. Supply chain considerations revolve around raw material costs, manufacturing scale, and regulatory compliance, influencing pricing.

Market Challenges

  • Market saturation: Convoluted differentiation in formulations limits premium pricing.
  • Pricing pressure from generics: Increased competition has led to declining prices, particularly in OTC markets.
  • Limited patent protection: Many ammonium lactate products are off-patent, reducing opportunities for exclusive pricing strategies.

Price Projections for Ammonium Lactate

Current Pricing Dynamics

Pricing varies based on formulation concentration, packaging, brand, and market segment (OTC vs prescription). Typical retail prices for a 473 ml (16 oz) bottle of 12% ammonium lactate cream or lotion hover around $10–$15 in North America, with generics often priced lower, around $5–$10 [3].

The wholesale price for manufacturers ranges from $2–$4 per bottle, influenced by raw material costs and manufacturing efficiency. Generic unbranded products tend to be priced at the lower end of the spectrum.

Projected Price Trends (2023–2027)

Given current market dynamics, the following trends are anticipated:

  • Moderate Price Decline (-1% to -3% annually): As more generics enter the market and production scales up, prices are expected to decline marginally.
  • Potential Premiums for Specialized Formulations (+2% annually): Innovation in delivery mechanisms or formulations (e.g., preservative-free, organic) could command higher prices in niche segments.
  • Impact of Raw Material Costs: Fluctuations in raw material prices, particularly lactic acid derivatives, will influence manufacturing costs and product pricing.

By 2027, average retail prices are projected to hover around $8–$12 for standard products, with wholesale costs potentially falling below $2.50 per unit for high-volume producers.

Influencing Factors on Price Projections

  • Market Competition: Increased generic penetration will sustain downward pricing pressure.
  • Regulatory Changes: Stricter safety or labeling requirements could raise manufacturing costs, moderating price reductions.
  • Patent and IP Landscape: Expiry of patents in certain formulations will further commoditize the product.

Strategic Implications

Manufacturers aiming to sustain profitability must focus on:

  • Innovating formulations to differentiate offerings and justify premium pricing.
  • Optimizing production efficiencies to offset declining margins.
  • Expanding into emerging markets, where demand for affordable dermatological therapies is rising.
  • Engaging in strategic collaborations to enhance distribution and market reach.

Investors should consider the commoditized nature of ammonium lactate and favor companies that invest in product innovation or geographic expansion to buffer declining average prices.


Key Takeaways

  • The global ammonium lactate market is growing steadily, driven by dermatological needs and skincare trends.
  • Price competition, especially from generics, is intensifying, leading to gradual price declines.
  • Innovation in formulations can create niche segments with higher margins.
  • Market saturation and patent expirations will continue to exert downward pressure.
  • Strategic focus on product differentiation and international expansion offers growth opportunities.

FAQs

1. What factors influence the pricing of ammonium lactate products?
Pricing is primarily affected by raw material costs, manufacturing efficiency, market competition from generics, formulation innovations, regulatory compliance, and regional market dynamics.

2. How does patent expiry impact ammonium lactate pricing?
Patent expirations lead to increased generic competition, typically resulting in reduced prices and narrower profit margins for brand-name products.

3. Are organic or preservative-free ammonium lactate formulations priced higher?
Yes. Such specialized formulations often command premium pricing due to consumer demand for cleaner skincare options and perceived enhanced safety profiles.

4. Which regions are expected to see the fastest market growth?
The Asia-Pacific region is projected to experience rapid growth owing to rising disposable incomes, expanding skincare markets, and increased dermatology awareness.

5. What strategies can manufacturers adopt to maintain profitability?
Innovating formulations for niche markets, improving manufacturing efficiencies, expanding into emerging markets, and fostering strategic partnerships are key strategies.


References

[1] Market Research Future, "Global Ammonium Lactate Market Analysis," 2022.
[2] Allied Market Research, "Dermatology Emollients and Moisturizers Industry Overview," 2021.
[3] Price analysis reports from pharmaceutical price tracking platforms, 2023.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.